Fig. 5.
![Fig. 5. Comparison of APC resistance ratios for deglycosylated human and bovine factor V. Purified human (○, •) and bovine (▵, ▴) factor V were treated with neuraminidase and N-glycanase under conditions as in Fig 1 and then APC resistance ratios were determined after diluting factor V ([•, ▴] glycosidase-treated; [○, ▵] untreated controls) in factor V-deficient plasma using APTT assays.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/89/12/10.1182_blood.v89.12.4348/3/bl_0038f5.jpeg?Expires=1735524357&Signature=Rql5SrIYRTgEe21CWW~KEj3sF-~vfYOhPh0PW8ltDowz172arOMtg3oBcuoi2YQ-EQDihT9XAdeOuFD1oZn4Fi8Mwh6xkX03jDb3BybJCWcvs9O~xeNWwjo5W-xnZJ1AiHW0~CxpiUox3CskAwm6fbSMjWGAuu-BMT0Vd3TKBhku7dYd9w89ERuZ4Bc8jKE6XNqX~BeF8J~idxa8Kk-B7qWesw0jXoLlZTsBGlsjZnbvnPaKsgWNYOe-V~nk2jN6wdkUMPLBwXF3uDDjhgQyRLYk81gsiI9DiI5qYK~KB3wpYHXZGQx0tVBIRF791sf5sdFTyC4HgcJ8VWg-c26Cog__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Comparison of APC resistance ratios for deglycosylated human and bovine factor V. Purified human (○, •) and bovine (▵, ▴) factor V were treated with neuraminidase and N-glycanase under conditions as in Fig 1 and then APC resistance ratios were determined after diluting factor V ([•, ▴] glycosidase-treated; [○, ▵] untreated controls) in factor V-deficient plasma using APTT assays.
